ISRCTN11492145 : Octapharma’s FVIII concentrates in previously untreated and minimally treated haemophilia A patients
- Overall trial status
- Recruitment status
...trials and registered for treatment of haemophilia A; however, as haemophilia A is a rare disease, only small numbers of patients have been treated. For previously untreated patients (PUPs)...